Objective: To know the truth how does Dengzhanxixin injection be used in clinical practice, and to regulate clinical use, and to direct the prospective study design.
Method: Twenty comprehensive hospital information system (HIS) data are collected. Cleaning up the database, then analysis the patients' information which the patients have used Dengzhanxixin injection. Using the basic description method and association rules to analysis the data.
Result: By analysis the Dengzhanxixin data come from HIS database we found that the most patient's age are elder than 45, it was used to treat ischemic stroke, coronary heart disease, diabetes and hypertension. It is always used in the form of intravenous injection, and are always used in 30-40 mL dosage in clinical practice, and it is always used for 14 days for one time.
Conclusion: The patients are usually used in old people. And the injection's using in clinical are mostly complied with the instructions. The patients who had been used Dengzhanxixin injection usually have diabetes and hypertension.